midterm Flashcards

1
Q

3 guiding principles of belmont report

A
  1. Respect for persons - informed consent and protection of vulnerable populations
  2. beneficence - do not harm. maximize benefits and minimize risk
  3. Justice - fair and equal treatment in bearing burdens and receiving benefits of research. Include diverse populations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

persons with diminished autonomy entitled to protection

A

children
mentally disabled
prisoners

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

informed consent process (respect for persons)

A

gives enough info to decide wether or not to participate
gives comprehension through understandable language and answering question
voluntariness free of coercion or influence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

IRB must consider

A

risk to subjects
benefits to subjects
importance of knowledge to be gained
informed consent process

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

IRB must report to federal agencies what?

A
  • Injuries to human subjects or unanticipated problems

* Serious or continuing noncompliance with regulations or IRB requirements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is consent?

A

consent must be informed, understood, and voluntary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Office for Human Research Protection (OHRP)

A

oversees Assurances –US institutions as well as international institutions receiving DHHS funds for research
federally funded research cannot be conducted until assurance is re-instated
has authority to terminate or suspend institution’s research

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Federal-Wide Assurance (FWA) aka assurance of compliance is needed before?

A

a federal grant or contract is awarded to institutions

FWA makes institution agree to federal regulations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Federal-Wide Assurance (FWA) aka assurance of compliance is needed before?

A

a federal grant or contract is awarded to institutions

FWA makes institutions agree to apply federal regulations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

IRB acts as?

A

federal government in conducting duty of supervising research

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

IRB acts as?

A

federal government in conducting duty of supervising research

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

research study with prisoners must be?

A

applicable to health concerns in prison setting like

hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

good clinical practice

A

protect participants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

good clinical practice branches?

A

FDA 21 CFR
OHRP (DHHS) 45 CFR 46
International council for harmonisation (ICH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

state and local regulations general rule

A

federal laws must be followed if stricter than state regulations
whichever is stricter must be followed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

21 CFR FDA regulated research

A

regulates:
financial disclosure for drug development
IRB

17
Q

how long are study records maintained?

A

minimum of 2 years after FDA approval or discontinuation

3 yrs after completion of study for DHHS

18
Q

ICH

A

international board that sets standards for the pharmaceutical industry

19
Q

confidentiality certificate

A

protects information about subjects against a legal order to discover data
given by NIH and IRB tells you to get it

20
Q

levels of IRB protocol review

A

exempt - review protocols that are minimal risk. usually retrospective. IRB not required if subject cannot be identified. ONLY IRB decides if exemption applies or not
expedited - reviews protocols that are minimal risk and can be retrospective or prospective. having 3 members of IRB can give you permission instead of the full board. may not be allowed if subject ID poses risk of privacy protection. consent can be waived
full board - for research with greater than minimal risk

21
Q

levels of IRB review

A

exempt - reviews protocol that are minimal risk. usually retrospective. IRB not required if subject cannot be identified. ONLY IRB decides if exemption applies or not
expedited - review protocol that are minimal risk and can be retrospective or prospective. having 3 members of IRB can give you permission instead of the full board. may not be allowed if subject ID poses risk of privacy protection. consent can be waived
full board - for research with greater than minimal risk

22
Q

informed consent review lets subjects know about?

A
risks
purpose
benefits
disclosure
confidentiality
compensation
answers to questions
voluntariness
23
Q

protocol deviations

A

decrease credibility of data and affect licensing of drug

24
Q

adverse event

A

any deterioration in health status wether or not associated with drug must be reported
like hospitalization, a finding in PE, symptom,

25
Q

adverse drug rxn

A

due to a drug must also be reported

26
Q

unexpected adverse event

A

new event not listed on risk information in protocol or investigator brochure.

27
Q

serious adverse events must be reported to IRB within?

A

24 hours

28
Q

final rule

A

no research misconduct by fabrication, falsification or other practices that deviate from scientific community
intentional flaw

29
Q

what are the simple concepts that drive decision making when implementing clinical trials?

A

subject welfare
data validity
control of investigational product

30
Q

Good Clinical Practice in US

FDA 21 CFR

A

Electronic documents informed consent

Financial disclosure

IRBs

IND (investigational new drug) and NDA (new drug application)

Biologics

devices

31
Q

Good Clinical Practice in US

OHRP (DHHS) 45 CFR 46

A

IRBs and informed consent

Protection of pregnant women, fetuses, neonates, prisoners, children

Registration of IRB

32
Q

Good Clinical Practice in US

ICH

A

International board that sets standards for pharmaceutical industry

33
Q

Expected adverse event vs unexpected adverse event

A

expected adverse event - adverse experience/ risk information in sponsor protocol or investigator brochure
unexpected adverse event - any adverse experience not constistent with risk info described in sponsor protocol or investigator brochure